Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Greg M Miller"'
Autor:
Eleftherios P. Diamandis, Michele J. Petrovic, Allison Klotz, David G. McLeod, Jeonifer Garren, Nischal Mahaveer Chand, Jennifer Cullen, Inger L. Rosner, Neil Fleshner, Tracey Friss, Mark D. Kellogg, C. Bountra, Rangaprasad Sarangarajan, Stephen J. Freedland, Michael A. Kiebish, Leonardo O. Rodrigues, Shen Luan, Greg M Miller, Wenfang Wu, Niven R. Narain, Amina Ali, Saurabh Patil, Albert Dobi, Sandra Laszlo, Poornima Tekumalla, Alagarsamy Srinivasan, Elder Granger, Viatcheslav R. Akmaev, Shiv K. Srivastava, Shobha Ravipaty
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Prostate-specific antigen (PSA) screening for prostate cancer (PCa) is limited by the lack of specificity but is further complicated in the benign prostatic hyperplasia (BPH) population which also exhibit elevated PSA, representing a clear unmet need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dcd340888251555adc220c2e3973bad
https://pubmed.ncbi.nlm.nih.gov/34302010
https://pubmed.ncbi.nlm.nih.gov/34302010
Autor:
Lawrence Recht, Niven R. Narain, Valerie Bussberg, Greg M Miller, Richard Searfoss, Kennedy Ofori-Mensa, Punit P. Shah, Vladimir Tolstikov, Rangaprasad Sarangarajan, Elder Granger, Seema Nagpal, Can Bruce, Michael A. Kiebish, Leonardo O. Rodrigues, Bennett Greenwood
Publikováno v:
Journal of Clinical Oncology. 39:2059-2059
2059 Background: BPM 31510-IV is a drug-lipid conjugate nanodispersion containing oxidized Coenzyme Q10 (CoQ10) in clinical development for glioblastoma multiforme (GBM). In a recently concluded Phase 1 study of BPM 31510-IV (NCT03020602), in additio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ea902a02895d5b080944cc69c316270
https://doi.org/10.1200/jco.2021.39.15_suppl.2059
https://doi.org/10.1200/jco.2021.39.15_suppl.2059